Literature DB >> 27581799

A Simple Food-Diverting Operation for Type 2 Diabetes Treatment. Preliminary Results in Humans with BMI 28-32 kg/m2.

John Melissas1, Halit ErenTaskin2, Drakos Peirasmakis3, Efstathios Dimitriadis3, Marios Papadakis4, Seniyye Ulgen Zengin5, Volkan Yumuk6, Mustafa Taskin2.   

Abstract

BACKGROUND: The feasibility of a simple side-to-side jejunoileal anastomosis (SJA) in non-morbidly obese individuals to control type 2 diabetes mellitus (T2DM) was studied in six diabetic patients with BMI 28-32. This novel procedure was performed in two Academic Centers and preliminary data is presented.
METHODS: SJA bypassing a significant part of the small bowel and diverting food and biliopancretic secretions to the distal ileum was performed laparoscopically in six diabetic patients with BMI 28-32 kg/m2. SJA was performed at a distance of 100 cm from the Treitz ligament and 150 cm from the ileocecal valve, thus a total bowel alimentary and biliopancreatic loop length of 2.5 m was created.
RESULTS: Three of the patients (two female, one male) experienced complete remission of diabetes from the immediate postoperative period and up to 3 years after the procedure. Two other patients remained medication-free after the operation experiencing partial diabetes remission, and the third patient significantly reduced his daily insulin requirements immediately after surgery. There were no early or late postoperative complications.
CONCLUSIONS: A simple SJA, diverting the food and biliopancreatic secretion to the distal small bowel, was able to control T2DM in all patients offering total or partial remission of the disease soon after the procedure. Those preliminary data and the simplicity of the operation are encouraging and promising. However, further studies are in progress in both Institutions to reveal the possible mechanism of diabetes control and investigate the effect of this operation on larger number of patients, with longer follow-up period.

Entities:  

Keywords:  Diabetes type 2; Jejunoileal anastomosis; Metabolic surgery

Mesh:

Substances:

Year:  2017        PMID: 27581799     DOI: 10.1007/s11695-016-2251-8

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  24 in total

1.  Sleeve gastrectomy plus side-to-side jejunoileal anastomosis for the treatment of morbid obesity and metabolic diseases: a promising operation.

Authors:  John Melissas; Anastasia Peppe; John Askoxilakis; Efstathios Dimitriadis; John Grammatikakis
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

2.  Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases.

Authors:  Ricardo V Cohen; Carlos A Schiavon; José S Pinheiro; Jose Luiz Correa; Francesco Rubino
Journal:  Surg Obes Relat Dis       Date:  2007 Mar-Apr       Impact factor: 4.734

Review 3.  The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus.

Authors:  Francesco Rubino; Lee M Kaplan; Philip R Schauer; David E Cummings
Journal:  Ann Surg       Date:  2010-03       Impact factor: 12.969

4.  The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.

Authors:  Francesco Rubino; Antonello Forgione; David E Cummings; Michel Vix; Donatella Gnuli; Geltrude Mingrone; Marco Castagneto; Jacques Marescaux
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

5.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

6.  Improvement in insulin sensitivity and β-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms.

Authors:  Aureo Ludovico De Paula; Alessandro R Stival; Alfredo Halpern; Carolina C L DePaula; Andrea Mari; Elza Muscelli; Sergio Vencio; Ele Ferrannini
Journal:  J Gastrointest Surg       Date:  2011-05-10       Impact factor: 3.452

7.  Gastric bypass in the treatment of type 2 diabetes in patients with a BMI of 30 to 35 kg/m2.

Authors:  Vladimir Curvelo Tavares de Sa; Alvaro A Ferraz; Josemberg M Campos; Almino C Ramos; Jose Guido C Araujo; Edmundo M Ferraz
Journal:  Obes Surg       Date:  2011-03       Impact factor: 4.129

8.  Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.

Authors:  G Mingrone
Journal:  Nutr Metab Cardiovasc Dis       Date:  2008-10       Impact factor: 4.222

Review 9.  Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.

Authors:  Renee E Amori; Joseph Lau; Anastassios G Pittas
Journal:  JAMA       Date:  2007-07-11       Impact factor: 56.272

10.  Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity.

Authors:  Akila De Silva; Stephen R Bloom
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

View more
  4 in total

1.  Small Intestinal Bypass Induces a Persistent Weight-Loss Effect and Improves Glucose Tolerance in Obese Rats.

Authors:  Jiaqing Cao; Quan Ren; Cai Tan; Jinyuan Duan
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

2.  A rodent model of partial intestinal diversion: a novel metabolic operation.

Authors:  Rafael Alvarez; Darleen A Sandoval; Randy J Seeley
Journal:  Surg Obes Relat Dis       Date:  2019-11-07       Impact factor: 4.734

3.  Proximal Jejunal Bypass Improves the Outcome of Gastric Clip in Patients with Obesity and Type 2 Diabetes Mellitus.

Authors:  Seh-Huang Chao; Chia-Lin Lin; Wei-Jei Lee; Jung-Chien Chen; Ju Jun Chou
Journal:  Obes Surg       Date:  2019-04       Impact factor: 4.129

4.  A novel approach to glycemic control in type 2 diabetes mellitus, partial jejunal diversion: pre-clinical to clinical pathway.

Authors:  Martin Fried; Karin Dolezalova; Adam P Chambers; Elliott J Fegelman; Robin Scamuffa; Michael L Schwiers; Jason R Waggoner; Martin Haluzik; Randy J Seeley
Journal:  BMJ Open Diabetes Res Care       Date:  2017-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.